BrightSpring Health Services, Inc. Tangible Equity Unit financials
$188.43+2.24%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.87B | $3.61B | $3.55B | $3.33B | $3.15B | $2.88B | $2.75B | $2.60B | $2.44B | $2.29B |
| Gross profit | $492.7M | $482.2M | $412.5M | $392.0M | $374.9M | $338.4M | $338.7M | $323.1M | $312.2M | $292.5M |
| Gross margin | 12.7% | 13.3% | 11.6% | 11.8% | 11.9% | 11.8% | 12.3% | 12.4% | 12.8% | 12.8% |
| Operating income | $130.4M | $121.4M | $108.1M | $87.8M | $48.6M | $50.7M | $55.5M | $29.1M | $38.7M | -$15.3M |
| Net income | $84.3M | $148.8M | $77.1M | $55.8M | $28.2M | $29.5M | $16.0M | -$8.2M | $19.9M | -$45.8M |
| Net margin | 2.2% | 4.1% | 2.2% | 1.7% | 0.9% | 1.0% | 0.6% | −0.3% | 0.8% | −2.0% |
| Diluted EPS | $0.38 | $0.67 | $0.34 | $0.26 | $0.13 | $0.14 | $0.08 | $-0.04 | $0.10 | $-0.26 |
| EBITDA | $171.8M | $160.5M | $147.6M | $128.6M | $90.4M | $92.9M | $110.4M | $79.7M | $88.7M | $33.6M |
| Operating cash flow | $43.9M | $122.9M | $231.6M | $107.9M | $49.1M | $101.6M | $90.6M | $27.2M | -$15.2M | -$78.9M |
| Free cash flow | $14.9M | $101.4M | $193.9M | $92.2M | $24.7M | $84.0M | $75.3M | $7.2M | -$39.0M | -$100.7M |
| Diluted shares | 220.3M | 221.3M | 229.9M | 218.0M | 216.3M | 214.9M | 189.0M | 198.5M | 209.0M | 175.5M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $550.4M | $888.8M | $88.4M | $140.3M | $70.1M | $52.3M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $2.21B | $2.52B | $2.53B | $2.53B | $2.54B | $2.55B |
| Total assets | $5.99B | $6.21B | $6.41B | $6.05B | $5.94B | $5.85B |
| Total liabilities | $3.93B | $4.22B | $4.53B | $4.23B | $4.20B | $4.16B |
| Shareholders' equity | $2.05B | $1.98B | $1.88B | $1.82B | $1.74B | $1.69B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology